Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 58.45
+4.65 (8.64%)
At close: Mar 27, 2026
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 41.27 billion as of March 27, 2026. Its market cap has increased by 846.15% in one year.
Market Cap
41.27B
Enterprise Value
41.55B
Revenue
1.53B
Ranking
n/a
PE Ratio
122.15
Stock Price
58.45
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 41.27B, an increase of 300.10%. That is a compound annual growth rate of 47.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 41.27B | 77.63% |
| Dec 31, 2025 | 23.23B | 584.32% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 65.14B |
| 3SBio | 55.80B |
| Shanghai Henlius Biotech | 36.50B |
| Shanghai Junshi Biosciences | 33.84B |
| TransThera Sciences (Nanjing) | 27.47B |
| InnoCare Pharma | 25.02B |
| Genscript Biotech | 24.07B |
| Duality Biotherapeutics | 23.72B |